ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,221.42
-0.02%
US Tech 100
17,716.80
0.19%
다우존스 지수
39,431.51
-0.21%
Bitcoin
62,503.88
-0.64%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Genetic Technologies Ltd (GENE)

  7. Genetic Technologies Ltd (GENE) 뉴스

GENE

Genetic Technologies (GENE)

Genetic Technologies Ltd
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:GENE
일자시간출처헤드라인심볼기업
2024/05/0621:00GlobeNewswire Inc.GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employeesNASDAQ:GENEGenetic Technologies Ltd
2024/04/2304:00GlobeNewswire Inc.Genetic Technologies Announces Closing of US$2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
2024/04/1901:17GlobeNewswire Inc.Genetic Technologies Announces $2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
2024/04/1721:00GlobeNewswire Inc.New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment OutcomesNASDAQ:GENEGenetic Technologies Ltd
2024/04/1621:00GlobeNewswire Inc.GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on YearNASDAQ:GENEGenetic Technologies Ltd
2024/04/1121:00GlobeNewswire Inc.GTG to pilot GeneType in Breast Screen centers across the U.S.NASDAQ:GENEGenetic Technologies Ltd
2024/04/0821:00GlobeNewswire Inc.EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”NASDAQ:GENEGenetic Technologies Ltd
2024/04/0221:05GlobeNewswire Inc.Genetic Technologies’ Digital Strategy Ignites Significant Traction in US MarketNASDAQ:GENEGenetic Technologies Ltd
2024/03/2621:00GlobeNewswire Inc.GTG Global Collaborations and Innovation UpdateNASDAQ:GENEGenetic Technologies Ltd
2024/03/2521:00GlobeNewswire Inc.GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised HealthcareNASDAQ:GENEGenetic Technologies Ltd
2024/02/2622:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
2024/02/1522:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
2024/02/1504:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GENEGenetic Technologies Ltd
2024/01/3122:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
2024/01/3122:00GlobeNewswire Inc.Launching our most comprehensive test and expanding into new global marketsNASDAQ:GENEGenetic Technologies Ltd
2024/01/0922:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
2024/01/0522:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
2024/01/0522:00GlobeNewswire Inc.Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:GENEGenetic Technologies Ltd
2024/01/0514:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GENEGenetic Technologies Ltd
2023/12/2822:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
2023/12/2722:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
2023/12/2107:00Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:GENEGenetic Technologies Ltd
2023/12/1422:00GlobeNewswire Inc.GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized WellnessNASDAQ:GENEGenetic Technologies Ltd
2023/12/1222:00GlobeNewswire Inc.Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio ChangeNASDAQ:GENEGenetic Technologies Ltd
2023/10/3021:00GlobeNewswire Inc.Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical TrialNASDAQ:GENEGenetic Technologies Ltd
2023/10/1821:30GlobeNewswire Inc.GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and TreatmentNASDAQ:GENEGenetic Technologies Ltd
2023/09/2722:00GlobeNewswire Inc.GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital NetworkNASDAQ:GENEGenetic Technologies Ltd
2023/09/1221:00GlobeNewswire Inc.Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian ReleaseNASDAQ:GENEGenetic Technologies Ltd
2023/09/1121:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
2023/09/1121:30GlobeNewswire Inc.GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry PartnerNASDAQ:GENEGenetic Technologies Ltd
 검색 관련기사 보기:NASDAQ:GENE

최근 히스토리

NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AAPL
Apple
NYSE
JPM
JP Morgan Chase
NYSE
MCD
McDonalds
COIN
BTCUSD
Bitcoin
FX
USDEUR
US Dollar vs Euro
AMEX
XLF
Financial Select Sector
NYSE
KO
Coca Cola
NYSE
CVX
Chevron
NYSE
AXP
American Express
CCOM
US500
US 500
CCOM
US100
US Tech 100
USI
USTECH100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유